FP 7832

Drug Profile

FP 7832

Alternative Names: FP-7832

Latest Information Update: 06 Jun 2007

Price : $50

At a glance

  • Originator Faust Pharmaceuticals
  • Class
  • Mechanism of Action Cholinergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease

Most Recent Events

  • 06 Jun 2007 Discontinued - Preclinical for Alzheimer's disease in France (unspecified route)
  • 14 Jan 2004 Preclinical trials in Alzheimer's disease in France (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top